|
|
|
| Research Progress of PI3K/AKT/mTOR Signaling Pathway in Targeted Therapy for Triple-negative Breast Cancer |
| YANG Guannan, ZHANG Xuepeng |
| First-author's address: Department of Oncology, the Affiliated Hospital of North China University of Science and Technology, Tangshan 063000, China |
|
|
